-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Search results for: “patient perspective”
-
Patient Perspective: Me, Myself, and Scanxiety
Studies that don’t show survival benefit with more frequent surveillance won’t convince patients they’re better off without scans. Even if regularly scheduled scans don’t help patients live longer, they do help them live better.
-
Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
Patient Advocates Committee Chair Jill Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the burden of lung cancer worldwide.
-
About Us
About ILCN IASLC Lung Cancer News is published bimonthly by the International Association for the Study of Lung Cancer (IASLC). For more information email Erin Jungmeyer at [email protected]. ILCN Editorial Group Corey J. Langer, MD, FACP Editor Associate Editors Mary Jo Fidler, MD Associate Editor Witold K. Rzyman, MD Associate Editor Suresh Senan, MD Associate Editor…
-
Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines
In part 3 of our series on palliative and supportive care, Prof. Sun-Hyun Kim discusses the need for non-Western perspectives in recommendations for advanced care planning.
-
ILCN Names New Associate Editors
Long-time editorial group members, Drs. Mary Jo Fidler, Witold Rzyman, and Suresh Senan bring disciplinary diversity to ILCN’s leadership.
-
From the Editor: Looking Back on 2022
ILCN Editor Dr. Corey J. Langer reflects on highlights from the past year and looks at the year to come.
-
Passing of The Baton—On the Death of Patient Research Advocates
Patient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says.
-
In Brief for Dec. 21, 2022
IASLC names J. Michael Hoehn COO. FDA approves adagrasib for KRAS G12C-mutated NSCLC. NHS England increases access to screening in effort to catch cancers earlier.
-
In Brief for Dec. 7, 2022
Learn how new guidance from the UK’s National Institutes for Health Care Excellence addresses an unmet clinical need for patients with EGFR+ NSCLC with exon 20 insertion and stay up to date on the latest meeting news from IASLC.
-
Closing Plenary Addresses Access to Screening, Drugs
Profession challenged to double survival rates within 5 years. Improving screening, reducing barriers to treatments will be key.
View ILCN Archives
Provider Resources
Popular Articles